TGFB1 and cancer: Accordingly, based on immunohistochemistry staining, Ohtani et al. have observed that the latent form of TGF-β1 is mainly localised in immune cells instead of cancer cells, with macrophages, DCs, and T cells being the predominant sources of latent TGF-β1 in cancer stroma [71].